Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(0.83)
# 3,929
Out of 5,182 analysts
181
Total ratings
21.76%
Success rate
-10.48%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.37 | +556.93% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $1.10 | +18,081.82% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $6.20 | +206.45% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.20 | +233.33% | 7 | Apr 8, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $2.56 | +7,712.50% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.95 | +544.07% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $14.26 | +47.27% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $0.85 | +1,669.91% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $2.19 | +25,470.78% | 9 | Mar 10, 2025 | |
| ENVB Enveric Biosciences | Reiterates: Buy | $120 | $5.32 | +2,155.64% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.18 | +457.10% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $3.57 | +2,421.01% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.92 | +139.90% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.48 | +359.77% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.81 | +640.65% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.65 | +15,282.25% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $2.91 | +6,772.85% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.55 | +684.31% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.59 | +343,411.45% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $7.09 | +6,952.19% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $31.97 | +650.70% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.88 | +9,022.01% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $14.60 | +54,694.52% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.51 | +363.58% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.14 | +2,531.58% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.27 | +836.77% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.04 | +492.11% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.32 | +115.52% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $60.69 | -60.45% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.59 | +580,446.60% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.04 | +1,826,823.08% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.37
Upside: +556.93%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $1.10
Upside: +18,081.82%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $6.20
Upside: +206.45%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.20
Upside: +233.33%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $2.56
Upside: +7,712.50%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.95
Upside: +544.07%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $14.26
Upside: +47.27%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.85
Upside: +1,669.91%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $2.19
Upside: +25,470.78%
Enveric Biosciences
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $5.32
Upside: +2,155.64%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $7.18
Upside: +457.10%
Mar 4, 2025
Reiterates: Buy
Price Target: $90
Current: $3.57
Upside: +2,421.01%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.92
Upside: +139.90%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.48
Upside: +359.77%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.81
Upside: +640.65%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.65
Upside: +15,282.25%
Nov 12, 2024
Reiterates: Buy
Price Target: $200
Current: $2.91
Upside: +6,772.85%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.55
Upside: +684.31%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.59
Upside: +343,411.45%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $7.09
Upside: +6,952.19%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $31.97
Upside: +650.70%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.88
Upside: +9,022.01%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $14.60
Upside: +54,694.52%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.51
Upside: +363.58%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.14
Upside: +2,531.58%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.27
Upside: +836.77%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $3.04
Upside: +492.11%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.32
Upside: +115.52%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $60.69
Upside: -60.45%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.59
Upside: +580,446.60%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.04
Upside: +1,826,823.08%